查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1561533

2024-2032 年按产品、应用、疾病类型和地区分類的人类微生物组市场报告

Human Microbiome Market Report by Product, Application, Disease Type, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 142 Pages | 商品交期: 2-3个工作天内

价格

2023年，全球人类微生物组市场IMARC Group达到8.17亿美元。

人类微生物组是指人类遗传肖像或宏基因组中发现的各种微生物内存在的基因。它由各种微生物组成，如细菌、真菌、原生动物、非生命病毒和众多单细胞生物。这些生物体会影响人类生理机能，并有助于增强或损害代谢和免疫功能。它们存在于人体组织中，并针对医学进步和分析技术进行研究。微生物组可用于益生菌、益生元、药物以及各种疾病的诊断和治疗系统，例如糖尿病、肥胖、癌症和代谢、胃肠道、神经系统、中枢神经系统和自体免疫疾病。

人类微生物组市场趋势：

全球微生物失调导致的慢性生活方式疾病和感染的盛行率不断上升，是推动市场成长的关键因素之一。此外，老年人口的增加更容易患此类疾病，这也推动了市场的成长。市场的成长也可归因于人们越来越重视开发具有增强功效的人类微生物组疗法。例如，人类肠道微生物组正在以特定的组合进行开发，以有效治疗各种胃肠道疾病。与此一致的是，冠状病毒（COVID-19）大流行的爆发也为市场成长提供了推动力。研究人员正在广泛研究肺部微生物组，以分析感染的严重程度并开发适当的治疗方法和疫苗。此外，各种进步，例如基于目标特异性微生物组的疗法的开发，也有利于市场的成长。其他因素，包括广泛的研发（R&D）活动，以及製药业（尤其是发展中经济体）的显着成长，预计将推动市场成长。

本报告回答的关键问题：

  • 迄今为止，全球人类微生物组市场表现如何，未来几年将如何表现？
  • COVID-19 对全球人类微生物组市场有何影响？
  • 主要区域市场有哪些？
  • 基于产品的市场区隔是什么？
  • 基于应用的市场区隔是什么？
  • 根据疾病类型的市场划分是怎样的？
  • 产业价值链的各个阶段是什么？
  • 该行业的关键驱动因素和挑战是什么？
  • 全球人类微生物组市场的结构如何？
  • 产业竞争程度如何？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球人类微生物组市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依产品

  • 益生菌
    • 市场趋势
    • 市场预测
  • 益生元
    • 市场趋势
    • 市场预测
  • 诊断测试
    • 市场趋势
    • 市场预测
  • 药品
    • 市场趋势
    • 市场预测
  • 医疗食品
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 7 章：市场区隔：按应用

  • 疗法
    • 市场趋势
    • 市场预测
  • 诊断
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：依疾病类型

  • 肥胖
    • 市场趋势
    • 市场预测
  • 糖尿病
    • 市场趋势
    • 市场预测
  • 自体免疫疾病
    • 市场趋势
    • 市场预测
  • 癌症
    • 市场趋势
    • 市场预测
  • 胃肠道疾病
    • 市场趋势
    • 市场预测
  • 中枢神经系统疾病
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • 4D pharma plc
    • Atlas Biomed Group Limited
    • BIOHM
    • BiomX
    • Bione
    • DayTwo Inc.
    • ENTEROME
    • Ferring BV
    • Finch Therapeutics
    • Second Genome Inc.
    • SynBioBeta LLC
    • Synthetic Biologics Inc.
    • Vedanta Biosciences Inc.
    • Viome Inc.
Product Code: SR112024A4420

The global human microbiome market size reached US$ 817.0 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 3,586.3 Million by 2032, exhibiting a growth rate (CAGR) of 17.3% during 2024-2032.

The human microbiome refers to the genes present inside various microorganisms found in the genetic portrait, or metagenome, of humans. It consists of various microorganisms, such as bacteria, fungi, protozoans, non-living viruses and numerous single-celled organisms. These organisms impact human physiology and contribute to the enhancement or impairment of metabolic and immune functions. They are found in the human tissues and are studied for medical advancements and analytical techniques. Microbiomes are utilized in probiotics, prebiotics, pharmaceutical drugs and diagnostic and therapeutic systems for various ailments, such as diabetes, obesity, cancer and metabolic, gastrointestinal, neurological, central nervous system and autoimmune disorders.

Human Microbiome Market Trends:

The increasing prevalence of chronic lifestyle diseases and infections due to microbial dysbiosis across the globe is one of the key factors driving the market growth. Moreover, the rising geriatric population, which is more susceptible to such ailments, is providing a thrust to the market growth. The growth of the market can also be attributed to the increasing emphasis on the development of human microbiome therapeutics with enhanced efficacy. For instance, human gut microbiomes are being developed in specific combinations for the effective treatment of various gastrointestinal ailments. In line with this, the onset of the coronavirus (COVID-19) pandemic is also providing a thrust to the market growth. Researchers are extensively studying the lung microbiomes to analyze the severity of the infections and develop appropriate therapeutics and vaccines. Additionally, various advancements, such as the development of target-specific microbiome-based therapies, are also favoring the growth of the market. Other factors, including extensive research and development (R&D) activities, along with significant growth in the pharmaceutical industry, especially in the developing economies, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global human microbiome market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, application and disease type.

Breakup by Product:

  • Probiotics
  • Prebiotics
  • Diagnostic Tests
  • Drugs
  • Medical Food
  • Others

Breakup by Application:

  • Therapeutics
  • Diagnostics

Breakup by Disease Type:

  • Obesity
  • Diabetes
  • Autoimmune Disorders
  • Cancer
  • Gastrointestinal Disorders
  • Central Nervous System Disorders
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 4D pharma plc, Atlas Biomed Group Limited, BIOHM, BiomX, Bione, DayTwo Inc., ENTEROME, Ferring B.V., Finch Therapeutics, Second Genome Inc., SynBioBeta LLC, Synthetic Biologics Inc., Vedanta Biosciences Inc. and Viome Inc.

Key Questions Answered in This Report:

  • How has the global human microbiome market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global human microbiome market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the disease type?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global human microbiome market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Human Microbiome Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Probiotics
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Prebiotics
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Diagnostic Tests
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Drugs
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Medical Food
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Others
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Therapeutics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Diagnostics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Disease Type

  • 8.1 Obesity
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Diabetes
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Autoimmune Disorders
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Cancer
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Gastrointestinal Disorders
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Central Nervous System Disorders
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast
  • 8.7 Others
    • 8.7.1 Market Trends
    • 8.7.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 4D pharma plc
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
    • 14.3.2 Atlas Biomed Group Limited
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 BIOHM
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 BiomX
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Bione
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 DayTwo Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 ENTEROME
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Ferring B.V.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Finch Therapeutics
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
    • 14.3.10 Second Genome Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 SynBioBeta LLC
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Synthetic Biologics Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
    • 14.3.13 Vedanta Biosciences Inc.
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
    • 14.3.14 Viome Inc.
      • 14.3.14.1 Company Overview
      • 14.3.14.2 Product Portfolio

List of Figures

  • Figure 1: Global: Human Microbiome Market: Major Drivers and Challenges
  • Figure 2: Global: Human Microbiome Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: Human Microbiome Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 4: Global: Human Microbiome Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Human Microbiome Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Human Microbiome Market: Breakup by Disease Type (in %), 2023
  • Figure 7: Global: Human Microbiome Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Human Microbiome (Probiotics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Human Microbiome (Probiotics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Human Microbiome (Prebiotics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Human Microbiome (Prebiotics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Human Microbiome (Diagnostic Tests) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Human Microbiome (Diagnostic Tests) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Human Microbiome (Drugs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Human Microbiome (Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Human Microbiome (Medical Food) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Human Microbiome (Medical Food) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Human Microbiome (Other Products) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Human Microbiome (Other Products) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Human Microbiome (Therapeutics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Human Microbiome (Therapeutics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Human Microbiome (Diagnostics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Human Microbiome (Diagnostics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Human Microbiome (Obesity) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Human Microbiome (Obesity) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Human Microbiome (Diabetes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Human Microbiome (Diabetes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Human Microbiome (Autoimmune Disorders) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Human Microbiome (Autoimmune Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Human Microbiome (Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Human Microbiome (Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Human Microbiome (Gastrointestinal Disorders) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Human Microbiome (Gastrointestinal Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Human Microbiome (Central Nervous System Disorders) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Human Microbiome (Central Nervous System Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Human Microbiome (Other Disease Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Human Microbiome (Other Disease Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: North America: Human Microbiome Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: North America: Human Microbiome Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: United States: Human Microbiome Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: United States: Human Microbiome Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Canada: Human Microbiome Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Canada: Human Microbiome Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Asia-Pacific: Human Microbiome Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Asia-Pacific: Human Microbiome Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: China: Human Microbiome Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: China: Human Microbiome Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Japan: Human Microbiome Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Japan: Human Microbiome Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: India: Human Microbiome Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: India: Human Microbiome Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: South Korea: Human Microbiome Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: South Korea: Human Microbiome Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Australia: Human Microbiome Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Australia: Human Microbiome Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Indonesia: Human Microbiome Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Indonesia: Human Microbiome Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Others: Human Microbiome Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Others: Human Microbiome Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Europe: Human Microbiome Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Europe: Human Microbiome Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Germany: Human Microbiome Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Germany: Human Microbiome Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: France: Human Microbiome Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: France: Human Microbiome Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: United Kingdom: Human Microbiome Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: United Kingdom: Human Microbiome Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Italy: Human Microbiome Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Italy: Human Microbiome Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Spain: Human Microbiome Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Spain: Human Microbiome Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Russia: Human Microbiome Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Russia: Human Microbiome Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Others: Human Microbiome Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Others: Human Microbiome Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Latin America: Human Microbiome Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Latin America: Human Microbiome Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Brazil: Human Microbiome Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Brazil: Human Microbiome Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Mexico: Human Microbiome Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Mexico: Human Microbiome Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Others: Human Microbiome Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Others: Human Microbiome Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Middle East and Africa: Human Microbiome Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Middle East and Africa: Human Microbiome Market: Breakup by Country (in %), 2023
  • Figure 86: Middle East and Africa: Human Microbiome Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 87: Global: Human Microbiome Industry: SWOT Analysis
  • Figure 88: Global: Human Microbiome Industry: Value Chain Analysis
  • Figure 89: Global: Human Microbiome Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Human Microbiome Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Human Microbiome Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Human Microbiome Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Human Microbiome Market Forecast: Breakup by Disease Type (in Million US$), 2024-2032
  • Table 5: Global: Human Microbiome Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Human Microbiome Market: Competitive Structure
  • Table 7: Global: Human Microbiome Market: Key Players